{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:39:32Z","timestamp":1792485572647,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Limited epidemiological data are available for headache disorders in Japan, and no recent studies have reported the impact of several primary headache disorders in Japan. This study aimed to report the up-to-date epidemiological data and impact of primary headaches on daily activities as well as the use of medical care, clinical features, and pain severity\/activity impairment using nationwide data in Japan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used anonymized online survey data coupled with medical claims data, from individuals aged 19\u201374\u00a0years old, that were provided by DeSC Healthcare Inc. The outcomes included the prevalence of migraine, tension-type headache, cluster headache, and other headache types stratified by age and sex, use of medical care, clinical features, medication use, and severity of pain\/activity impairment. All outcomes were examined separately for each headache type. This is the second paper reported concurrently with this research.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study population comprised 691\/1,441\/21\/5,208 individuals with migraine\/tension-type headache\/cluster headache\/other headache types, respectively. The prevalence of migraine and tension-type headache was higher in women than in men but was similar for cluster headache (male vs. female, 1.7% vs. 7.4%, 5.3% vs. 10.8%, and 0.1% vs. 0.1%, respectively). The percentage of individuals with migraine, tension-type headache, cluster headache who had not seen a doctor was 81.0%, 92.0%, 57.1%, respectively. The common headache triggers were fatigue in migraine and tension-type headache, and weather-related phenomena and turning of the seasons in migraine. Common activities refrained from or reduced by headaches were \u201coperating a computer or smartphone\u201d, \u201cdrinking alcohol\u201d, and \u201cgoing to crowded places\u201d in all three headache types and housework-related activities in women. Among individuals taking medicines, 16.8%, 15.8%, 47.6% with migraine, tension-type headache, and cluster headache reported moderate to severe pain, respectively, and 12.6%, 7.7%, 19.0% reported moderate to severe disability, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study found various triggers of headache attacks, and daily activities refrained from or reduced by headaches. Additionally, this study suggested that the disease burden in people possibly experiencing tension-type headaches, many of whom had not seen a doctor. The study findings are of clinical value for the diagnosis and treatment of primary headaches.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-023-03122-9","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T09:04:06Z","timestamp":1676970246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical characteristics, medication use, and impact of primary headache on daily activities: an observational study using linked online survey and medical claims data in Japan"],"prefix":"10.1186","volume":"23","author":[{"given":"Koichi","family":"Hirata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"issue":"11","key":"3122_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/s1474-4422(17)30299-5","volume":"16","author":"GBD","year":"2015","unstructured":"GBD. Neurological Disorders Collaborator Group (2017) Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2015;16(11):877\u201397. https:\/\/doi.org\/10.1016\/s1474-4422(17)30299-5.","journal-title":"Lancet Neurol"},{"key":"3122_CR2","unstructured":"Ministry of Health Labour and Welfare (2020). 2019 Comprehensive survey of living conditions: III. Household health conditions. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/k-tyosa\/k-tyosa19\/dl\/04.pdf [in Japanese] Accessed 16 Feb 2022."},{"key":"3122_CR3","doi-asserted-by":"publisher","unstructured":"Headache classification committee of the International Headache Society (IHS) (2018) The International classification of headache disorders, 3rd edition. Cephalalgia 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","DOI":"10.1177\/0333102417738202"},{"key":"3122_CR4","unstructured":"Headache Clinical Practice Guideline Development Committee (2021) Clinical practice guideline for headache disorders 2021. Edited by the Japanese Society of Neurology, the Japanese Headache Society, and Japanese Society of Neurological Therapeutics. Tokyo: Igakushoin. pp 1\u2013494."},{"issue":"1","key":"3122_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1468-2982.1997.1701015.x","volume":"17","author":"F Sakai","year":"1997","unstructured":"Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia. 1997;17(1):15\u201322. https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1701015.x.","journal-title":"Cephalalgia"},{"issue":"1","key":"3122_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1526-4610.2004.04004.x","volume":"44","author":"T Takeshima","year":"2004","unstructured":"Takeshima T, Ishizaki K, Fukuhara Y, Ijiri T, Kusumi M, Wakutani Y, et al. Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache. 2004;44(1):8\u201319. https:\/\/doi.org\/10.1111\/j.1526-4610.2004.04004.x.","journal-title":"Headache"},{"issue":"1","key":"3122_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s10194-019-1012-1","volume":"20","author":"K Ueda","year":"2019","unstructured":"Ueda K, Ye W, Lombard L, Kuga A, Kim Y, Cotton S, et al. Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme. J Headache Pain. 2019;20(1):68. https:\/\/doi.org\/10.1186\/s10194-019-1012-1.","journal-title":"J Headache Pain"},{"issue":"12","key":"3122_CR8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1177\/0333102419851855","volume":"39","author":"JL Meyers","year":"2019","unstructured":"Meyers JL, Davis KL, Lenz RA, Sakai F, Xue F. Treatment patterns and characteristics of patients with migraine in Japan: A retrospective analysis of health insurance claims data. Cephalalgia. 2019;39(12):1518\u201334. https:\/\/doi.org\/10.1177\/0333102419851855.","journal-title":"Cephalalgia"},{"issue":"1","key":"3122_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s10194-020-01180-9","volume":"21","author":"S Kikui","year":"2020","unstructured":"Kikui S, Chen Y, Todaka H, Asao K, Adachi K, Takeshima T. Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness Survey. J Headache Pain. 2020;21(1):110. https:\/\/doi.org\/10.1186\/s10194-020-01180-9.","journal-title":"J Headache Pain"},{"issue":"11","key":"3122_CR10","doi-asserted-by":"publisher","first-page":"e038987","DOI":"10.1136\/bmjopen-2020-038987","volume":"10","author":"H Igarashi","year":"2020","unstructured":"Igarashi H, Ueda K, Jung S, Cai Z, Chen Y, Nakamura T. Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey. BMJ Open. 2020;10(11):e038987. https:\/\/doi.org\/10.1136\/bmjopen-2020-038987.","journal-title":"BMJ Open"},{"issue":"1","key":"3122_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-021-01243-5","volume":"22","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Sakai F, Miyake H, Sone T, Sato M, Tanabe S, et al. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain. 2021;22(1):29. https:\/\/doi.org\/10.1186\/s10194-021-01243-5.","journal-title":"J Headache Pain"},{"issue":"2","key":"3122_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1055\/s-0030-1249220","volume":"30","author":"MS Robbins","year":"2010","unstructured":"Robbins MS, Lipton RB. The epidemiology of primary headache disorders. Semin Neurol. 2010;30(2):107\u201319. https:\/\/doi.org\/10.1055\/s-0030-1249220.","journal-title":"Semin Neurol"},{"issue":"1","key":"3122_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s10194-022-01439-3","volume":"23","author":"F Sakai","year":"2022","unstructured":"Sakai F, Hirata K, Igarashi H, Takeshima T, Nakayama T, Sano H, et al. A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan. J Headache Pain. 2022;23(1):70. https:\/\/doi.org\/10.1186\/s10194-022-01439-3.","journal-title":"J Headache Pain"},{"key":"3122_CR14","unstructured":"GlaxoSmithKline Research and Development Limited (GSK) (1992). Migraine-Specific Quality-of-Life Questionnaire (MSQ Version 2.1). https:\/\/eprovide.mapi-trust.org\/instruments\/migraine-specific-quality-of-life-questionnaire. Accessed 16 Feb 2022."},{"issue":"5","key":"3122_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365. https:\/\/doi.org\/10.2165\/00019053-199304050-00006.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"3122_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11136-012-0230-7","volume":"22","author":"R Rendas-Baum","year":"2013","unstructured":"Rendas-Baum R, Bloudek LM, Maglinte GA, Varon SF. The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Qual Life Res. 2013;22(5):1123\u201333. https:\/\/doi.org\/10.1007\/s11136-012-0230-7.","journal-title":"Qual Life Res"},{"issue":"1","key":"3122_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s41687-019-0138-x","volume":"3","author":"RM Speck","year":"2019","unstructured":"Speck RM, Shalhoub H, Ayer DW, Ford JH, Wyrwich KW, Bush EN. Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome. J Patient Rep Outcomes. 2019;3(1):39. https:\/\/doi.org\/10.1186\/s41687-019-0138-x.","journal-title":"J Patient Rep Outcomes"},{"issue":"3","key":"3122_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/01.wnl.0000078940.53438.83","volume":"61","author":"RB Lipton","year":"2003","unstructured":"Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61(3):375\u201382. https:\/\/doi.org\/10.1212\/01.wnl.0000078940.53438.83.","journal-title":"Neurology"},{"key":"3122_CR19","first-page":"134","volume":"42","author":"T Takeshima","year":"2015","unstructured":"Takeshima T, Sakai F, Suzuki N, Shimizu T, Igarashi H, Araki N, et al. A simple migraine screening instrument: validation study in Japan. Japanese J Headache. 2015;42:134\u201343.","journal-title":"Japanese J Headache"},{"issue":"4","key":"3122_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3988\/jcn.2021.17.4.546","volume":"17","author":"BK Kim","year":"2021","unstructured":"Kim BK, Cho SJ, Kim CS, Sakai F, Dodick DW, Chu MK. Disability and economic loss caused by headache among information technology workers in Korea. J Clin Neurol. 2021;17(4):546\u201357. https:\/\/doi.org\/10.3988\/jcn.2021.17.4.546.","journal-title":"J Clin Neurol"},{"issue":"5","key":"3122_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/0333102410391486","volume":"31","author":"N Imai","year":"2011","unstructured":"Imai N, Yagi N, Kuroda R, Konishi T, Serizawa M, Kobari M. Clinical profile of cluster headaches in Japan: low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessness. Cephalalgia. 2011;31(5):628\u201333. https:\/\/doi.org\/10.1177\/0333102410391486.","journal-title":"Cephalalgia"},{"issue":"8","key":"3122_CR22","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s10072-020-04332-6","volume":"41","author":"A Mart\u00ednez-Fern\u00e1ndez","year":"2020","unstructured":"Mart\u00ednez-Fern\u00e1ndez A, Rueda Vega M, Quintas S, de Toledo HM, D\u00edaz de Ter\u00e1n J, Latorre Gonz\u00e1lez G, et al. Psychosocial repercussion of migraine: is it a stigmatized disease? Neurol Sci. 2020;41(8):2207\u201313. https:\/\/doi.org\/10.1007\/s10072-020-04332-6.","journal-title":"Neurol Sci"},{"issue":"9488","key":"3122_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/s0140-6736(05)67217-0","volume":"366","author":"A May","year":"2005","unstructured":"May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet. 2005;366(9488):843\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(05)67217-0.","journal-title":"Lancet"},{"issue":"1","key":"3122_CR24","first-page":"4","volume":"28","author":"M Yokoyama","year":"2001","unstructured":"Yokoyama M, Hori S, Aoki K, Fujishima S, Kimura H, Suzuki M, Aikawa N. Headaches among patients admitted to emergency hospital care. Japanese Journal of Headache. 2001;28(1):4\u20135 ([in Japanese]).","journal-title":"Japanese Journal of Headache"},{"issue":"7","key":"3122_CR25","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jama.291.7.866","volume":"291","author":"RG Kowalski","year":"2004","unstructured":"Kowalski RG, Claassen J, Kreiter KT, Bates JE, Ostapkovich ND, Connolly ES, Mayer SA. Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA. 2004;291(7):866\u20139. https:\/\/doi.org\/10.1001\/jama.291.7.866.","journal-title":"JAMA"},{"issue":"1","key":"3122_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s10194-021-01276-w","volume":"22","author":"AH Poulsen","year":"2021","unstructured":"Poulsen AH, Younis S, Thuraiaiyah J, Ashina M. The chronobiology of migraine: a systematic review. J Headache Pain. 2021;22(1):76. https:\/\/doi.org\/10.1186\/s10194-021-01276-w.","journal-title":"J Headache Pain"},{"key":"3122_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-015-0540-6","volume":"16","author":"K Suzuki","year":"2015","unstructured":"Suzuki K, Miyamoto M, Miyamoto T, Numao A, Suzuki S, Sakuta H, et al. Sleep apnoea headache in obstructive sleep apnoea syndrome patients presenting with morning headache: comparison of the ICHD-2 and ICHD-3 beta criteria. J Headache Pain. 2015;16:56. https:\/\/doi.org\/10.1186\/s10194-015-0540-6.","journal-title":"J Headache Pain"},{"issue":"Suppl 12","key":"3122_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/0333102493013s1217","volume":"13","author":"NT Mathew","year":"1993","unstructured":"Mathew NT. Transformed migraine. Cephalalgia. 1993;13(Suppl 12):78\u201383. https:\/\/doi.org\/10.1177\/0333102493013s1217.","journal-title":"Cephalalgia"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03122-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T09:05:50Z","timestamp":1676970350000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03122-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3122"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03122-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this survey used only anonymized data and the authors, data analysts, and any parties involved in the study including Otsuka Pharmaceutical Co., Ltd. and Clinical Study Support Inc. did not possess or receive correspondence sheets, it was impossible for those involved to identify individuals included in the study. As the study using anonymized data is outside the scope of the national guidelines \u201cEthical Guidelines for Medical and Health Research Involving Human Subjects\u201d, the ethical committee review and individual-level consent were not required. However, the study protocol was approved by the ethics committee of the Research Institute of Healthcare Data Science (approval No.: RI2020012). Additionally, the study including the survey was performed in accordance with the Declaration of Helsinki (revised October 2013) by the World Medical Association and the Ethical Guidelines for Medical Research Involving Human Subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HS, HK, YS, and NK are employees of Otsuka Pharmaceutical Co., Ltd. (Japan). KH received consulting fees from Otsuka Pharmaceutical Co., Ltd., during the conduct of the study; consulting fees from Otsuka Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Amgen Astellas BioPharma K.K., and Lundbeck Japan K.K.; lecture Honoraria from Otsuka Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Eisai Co., Pfizer Japan, Daiichi Sankyo Co., Ltd., MSD Co., Ltd., Amgen Astellas BioPharma K.K., Ltd., and Lundbeck Japan K.K., outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}